Chrysalis Investment - Director/PDMR Shareholding

Chrysalis Investments

07/05/2026 11:38

RNS Number : 4390D

Chrysalis Investments Limited

07 May 2026

 

7 May 2026

 

Chrysalis Investments Limited (the "Company")

Director / PDMR shareholding

The Company wishes to announce in accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation the following dealing in the Company's ordinary shares of no-par value by persons discharging managerial responsibility.

 

Name
Samuel Dobbyn
Reason for the notification
Position/status
Independent Director of the Board
Initial Notification / Amendment
Initial Notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name
Chrysalis Investments Limited
LEI
213800F9SQ753JQHSW24
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument,
type of instrument Identification code
Ordinary shares of no par value ISIN: GG00BGJYPP46
Nature of the transaction
Purchase
Price(s) and volume(s)
Price: 0.8192
Volume: 61,027
Total Consideration: 49,993.32
Aggregated information
- Aggregated volume
- Price
N/A (Single Transaction)
Date of the transaction
6 May 2026
Place of the transaction
LONDON STOCK EXCHANGE, (XLON)

Additional Information


 

Details of the person discharging managerial responsibilities/person closely associated
Name
J Dobbyn
Reason for the notification
Position/status
PCA (Son of a Director of the Board)
Initial Notification / Amendment
Initial Notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name
Chrysalis Investments Limited
LEI
213800F9SQ753JQHSW24
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument,
type of instrument Identification code
Ordinary shares of no par value ISIN: GG00BGJYPP46
Nature of the transaction
Purchase
Price(s) and volume(s)
Price: 0.820773
Volume: 24,360
Total Consideration: 19,999.52
Aggregated information
- Aggregated volume
- Price
N/A (Single Transaction)
Date of the transaction
6 May 2026
Place of the transaction
LONDON STOCK EXCHANGE, (XLON)

 

Details of the person discharging managerial responsibilities/person closely associated
Name
E Dobbyn
Reason for the notification
Position/status
PCA (Daughter of a Director of the Board)
Initial Notification / Amendment
Initial Notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name
Chrysalis Investments Limited
LEI
213800F9SQ753JQHSW24
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument,
type of instrument Identification code
Ordinary shares of no par value ISIN: GG00BGJYPP46
Nature of the transaction
Purchase
Price(s) and volume(s)
Price: 0.8192
Volume: 24,407
Total Consideration: 19,994.21
Aggregated information
- Aggregated volume
- Price
N/A (Single Transaction)
Date of the transaction
6 May 2026
Place of the transaction
LONDON STOCK EXCHANGE, (XLON)

 

This announcement is made in accordance with the requirements of the EU Market Abuse Regulation ("MAR") and the Company confirms that the PDMR's notification obligations under MAR have also been satisfied.

 

-ENDS-

For further information, please contact
Media
Montfort Communications:
Charlotte McMullen / Imogen Saunders
+44 (0) 7921 881 800
chrysalis@montfort.london
Investment Adviser
Chrysalis Investment Partners LLP:
James Simpson
+44 (0) 20 7871 5343
G10 Capital Limited (AIFM):
+44 (0) 20 7397 5450
Maria Baldwin
Barclays Bank PLC:
Dion Di Miceli / Stuart Muress / James Atkinson
+44 (0) 20 7623 2323
Panmure Liberum:
Chris Clarke / Darren Vickers
+44 (0) 20 3100 2222
Deutsche Numis:
Nathan Brown / Matt Goss
+44 (0) 20 7260 1000
IQEQ Fund Services (Guernsey) Limited:
Aimee Gontier / Elaine Smeja
+44 (0) 1481 231852

 

 

LEI: 213800F9SQ753JQHSW24

 

 

A copy of this announcement will be available on the Company's website at https://www.chrysalisinvestments.co.uk

 

The information contained in this announcement regarding the Company's investments has been provided by the relevant underlying portfolio company and has not been independently verified by the Company. The information contained herein is unaudited.

 

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

The Company is an alternative investment fund ("AIF") for the purposes of the AIFM Directive and as such is required to have an investment manager who is duly authorised to undertake the role of an alternative investment fund manager ("AIFM"). The AIFM appointed is G10 Capital Limited (part of the IQEQ Group). Chrysalis Investment Partners LLP (FRN: 1009684) is an Appointed Representative of G10 Capital (FRN: 648953) Limited, which is authorised and regulated by the Financial Conduct Authority.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHBGGDULXGDGLR